W. R. Berkley Corporation (WRB)
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
$69.14-0.52%
Close 2026-09-04 · 1-day change
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
Research Workspace
Put WRB beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Property & Casualty Insurance is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Operating income growth to maintain or exceed Q1 2026 level: Operating income not reported.
View ThesisRevenue growth is slowing — up about 4% over the past year and decelerating.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskW. R. Berkley’s growth in specialty insurance has to keep compounding to justify the price. The company reported $452.3M net income, up 4.4% year over year, and beat earnings expectations. It trades at 2.8× P/B versus a 1.7× peer median, indicating the price reflects less growth than we forecast. If WRB cuts guidance on the next call, that could negatively impact expectations. Peer multiples imply a price about 21% above where it trades. This read is provisional.
Trailing returns as of 2026-09-04. WRB is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 18 analysts currently covering WRB (as of Sep 2026).
Based on 8 Wall Street analysts offering 12-month price targets for WRB in the last 4 months.
Continue this research
Compare WRB with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| WRB Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Property & Casualty Insurance — fair value, gap to price, and forward P/E.
Compare the value case
Put WRB next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Maintain excellent underwriting margins with select opportunities
New specialty unit enhances underwriting opportunities.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $69.14
The last 12 months of price, then the range of analyst 12-month targets from today’s $69.14.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Return significant capital to shareholders
Earnings beat and buybacks support capital return strategy.
Threatens: Exceed 15% after-tax return on equity
Earnings beat expectations but shares declined, indicating market concerns.
Advances: Maintain excellent underwriting margins with select opportunities
Strong underwriting performance boosts margins.
Threatens: Exceed 15% after-tax return on equity
Revenue miss raises concerns about growth sustainability.
Advances: Return significant capital to shareholders
Dividend hike and buyback reset enhance shareholder returns.
Upgrade suggests confidence in future performance.
New leadership can enhance operational effectiveness.